Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Achilles Therapeutics Plc ADR’s current trading price is -36.65% away from its 52-week high, while its distance from the 52-week low is 76.98%. The stock’s price range over this period has fluctuated between $0.63 and $1.76. The company, operating within the financial sector, had a trading volume of approximately 1.62 million for the day, which was noticeably higher than the average daily share volume of 0.13 million over the last 3 months.
Achilles Therapeutics Plc ADR experienced a rather steady stock market performance. The highest value in the past year was recorded at $1.76 on 02/29/24 and the lowest value was $0.63 on 08/28/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Achilles Therapeutics Plc ADR (ACHL) has experienced a quarterly rise of 16.74% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 45.83M and boasts a workforce of 215 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.9272, with a change in price of +0.3176. Similarly, Achilles Therapeutics Plc ADR recorded 478,297 in trading volume during the last 100 days, posting a change of +40.34%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ACHL stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.00.
ACHL Stock Stochastic Average
Today, Achilles Therapeutics Plc ADR’s raw stochastic average for the past 50 days stands at 92.42%, indicating a decline from the raw stochastic average of the last 20 days, which was 97.34%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 57.40% and 42.36% respectively.
ACHL Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant gain of 25.42% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 32.27%. Over the past 30 days, the price of ACHL has fallen by 5.19%. And in the last five days, it has surged by 15.31%.
